88 related articles for article (PubMed ID: 22957533)
1. Assessment of integrase interactor 1 (INI-1) expression in primary tumours of bone.
Tirabosco R; Jacques T; Berisha F; Flanagan AM
Histopathology; 2012 Dec; 61(6):1245-7. PubMed ID: 22957533
[No Abstract] [Full Text] [Related]
2. Anaplastic chordoma with loss of INI1 and brachyury expression in a 2-year-old girl.
Chavez JA; Nasir Ud Din ; Memon A; Perry A
Clin Neuropathol; 2014; 33(6):418-20. PubMed ID: 25074874
[No Abstract] [Full Text] [Related]
3. p63, CK7, PAX8 and INI-1: an optimal immunohistochemical panel to distinguish poorly differentiated urothelial cell carcinoma from high-grade tumours of the renal collecting system.
Carvalho JC; Thomas DG; McHugh JB; Shah RB; Kunju LP
Histopathology; 2012 Mar; 60(4):597-608. PubMed ID: 22260386
[TBL] [Abstract][Full Text] [Related]
4. Primary epithelioid sarcoma of bone: report of a unique case, with immunohistochemical and fluorescent in situ hybridization confirmation of INI1 deletion.
Raoux D; Péoc'h M; Pedeutour F; Vaunois B; Decouvelaere AV; Folpe AL
Am J Surg Pathol; 2009 Jun; 33(6):954-8. PubMed ID: 19342946
[TBL] [Abstract][Full Text] [Related]
5. Atypical ossifying fibromyxoid tumor unusually located in the mediastinum: report of a case showing mosaic loss of INI-1 expression.
Tajima S; Koda K
Int J Clin Exp Pathol; 2015; 8(2):2139-45. PubMed ID: 25973116
[TBL] [Abstract][Full Text] [Related]
6. Loss of SMARCB1/INI1 expression in poorly differentiated chordomas.
Mobley BC; McKenney JK; Bangs CD; Callahan K; Yeom KW; Schneppenheim R; Hayden MG; Cherry AM; Gokden M; Edwards MS; Fisher PG; Vogel H
Acta Neuropathol; 2010 Dec; 120(6):745-53. PubMed ID: 21057957
[TBL] [Abstract][Full Text] [Related]
7. Immunoprofile of mesenchymal chondrosarcoma: aberrant desmin and EMA expression, retention of INI1, and negative estrogen receptor in 22 female-predominant central nervous system and musculoskeletal cases.
Fanburg-Smith JC; Auerbach A; Marwaha JS; Wang Z; Santi M; Judkins AR; Rushing EJ
Ann Diagn Pathol; 2010 Feb; 14(1):8-14. PubMed ID: 20123451
[TBL] [Abstract][Full Text] [Related]
8. Comparative proteomics analysis of human osteosarcomas and benign tumor of bone.
Li Y; Liang Q; Wen YQ; Chen LL; Wang LT; Liu YL; Luo CQ; Liang HZ; Li MT; Li Z
Cancer Genet Cytogenet; 2010 Apr; 198(2):97-106. PubMed ID: 20362224
[TBL] [Abstract][Full Text] [Related]
9. Renal cell carcinoma with rhabdoid features and loss of INI1 expression in an individual without sickle cell trait.
Scarpelli M; Mazzucchelli R; Lopez-Beltran A; Cheng L; De Nictolis M; Santoni M; Montironi R
Pathology; 2014 Dec; 46(7):653-5. PubMed ID: 25393261
[No Abstract] [Full Text] [Related]
10. SMARCB1 expression in epithelioid sarcoma is regulated by miR-206, miR-381, and miR-671-5p on Both mRNA and protein levels.
Papp G; Krausz T; Stricker TP; Szendrői M; Sápi Z
Genes Chromosomes Cancer; 2014 Feb; 53(2):168-76. PubMed ID: 24327545
[TBL] [Abstract][Full Text] [Related]
11. Premature termination of SMARCB1 translation may be followed by reinitiation in schwannomatosis-associated schwannomas, but results in absence of SMARCB1 expression in rhabdoid tumors.
Hulsebos TJ; Kenter S; Verhagen WI; Baas F; Flucke U; Wesseling P
Acta Neuropathol; 2014 Sep; 128(3):439-48. PubMed ID: 24740647
[TBL] [Abstract][Full Text] [Related]
12. Malignant Ossifying Fibromyxoid Tumors: a report of two rare cases displaying retained INI1/SMARCB1 expression.
Rekhi B; Thorat S; Parikh G; Jambhekar NA
Indian J Pathol Microbiol; 2014; 57(4):652-3. PubMed ID: 25308036
[No Abstract] [Full Text] [Related]
13. Non-rhabdoid pediatric SMARCB1-deficient tumors: overlap between chordomas and malignant rhabdoid tumors?
Renard C; Pissaloux D; Decouvelaere AV; Bourdeaut F; Ranchère D
Cancer Genet; 2014 Sep; 207(9):384-9. PubMed ID: 25053104
[TBL] [Abstract][Full Text] [Related]
14. ERG and SALL4 expressions in SMARCB1/INI1-deficient tumors: a useful tool for distinguishing epithelioid sarcoma from malignant rhabdoid tumor.
Kohashi K; Yamada Y; Hotokebuchi Y; Yamamoto H; Taguchi T; Iwamoto Y; Oda Y
Hum Pathol; 2015 Feb; 46(2):225-30. PubMed ID: 25479928
[TBL] [Abstract][Full Text] [Related]
15. Expression of c-met proto-oncogene product (c-MET) in benign and malignant bone tumors.
Naka T; Iwamoto Y; Shinohara N; Ushijima M; Chuman H; Tsuneyoshi M
Mod Pathol; 1997 Aug; 10(8):832-8. PubMed ID: 9267827
[TBL] [Abstract][Full Text] [Related]
16. Uterine neoplasms composed of rhabdoid cells do not exhibit loss of INI1 immunoreactivity and are not related to childhood malignant rhabdoid tumor.
Al-Hussaini M; Hirschowitz L; McCluggage WG
Int J Gynecol Pathol; 2008 Apr; 27(2):236-42. PubMed ID: 18317218
[TBL] [Abstract][Full Text] [Related]
17. Glypican 3 expression in tumors with loss of SMARCB1/INI1 protein expression.
Kohashi K; Nakatsura T; Kinoshita Y; Yamamoto H; Yamada Y; Tajiri T; Taguchi T; Iwamoto Y; Oda Y
Hum Pathol; 2013 Apr; 44(4):526-33. PubMed ID: 23084579
[TBL] [Abstract][Full Text] [Related]
18. Integrase interactor 1 regulates proliferation, apoptosis and invasion in gastric cancer cells.
Wang XC; Li Y; Fan LQ; Tan BB; Li Z; Liu Y; Zhang ZD
Chin Med J (Engl); 2012 Feb; 125(3):527-32. PubMed ID: 22490415
[TBL] [Abstract][Full Text] [Related]
19. Expression of P-glycoprotein in high grade osteosarcomas with special emphasis on chondroblastic subtype.
Radig K; Häckel C; Herting J; Oda Y; Mittler U; Neumann W; Roessner A
Gen Diagn Pathol; 1997 Feb; 142(3-4):139-45. PubMed ID: 9065577
[TBL] [Abstract][Full Text] [Related]
20. The integrase interactor 1 (INI1) proteins facilitate Tat-mediated human immunodeficiency virus type 1 transcription.
Ariumi Y; Serhan F; Turelli P; Telenti A; Trono D
Retrovirology; 2006 Aug; 3():47. PubMed ID: 16889668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
